Epizyme appoints Jason P. Rhodes president
Mr. Rhodes, who was previously Executive Vice President and Chief Financial Officer, will continue to be Chief Financial Officer. Prior to joining Epizyme, from July 2007 to March 2010, Mr. Rhodes served as Vice President, Business Development at Alnylam Pharmaceuticals, Inc.
Prior to Alnylam, he was a founder and partner with Fidelity Biosciences, Fidelity Investments’ biopharma venture capital group. Mr. Rhod - July 4, 2013, Cambridge, Mass., USA – Epizyme, Inc., a clinical stage biopharmaceutical company, announced that Jason P. Rhodes has been named president of Epizyme.
Article continues below
Mr. Rhodes, who was previously Executive Vice President and Chief Financial Officer, will continue to be Chief Financial Officer. Prior to joining Epizyme, from July 2007 to March 2010, Mr. Rhodes served as Vice President, Business Development at Alnylam Pharmaceuticals, Inc. ■